NewsBenzingaAlpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients Benzinga 2026.10.22 12:32 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Fifth Third Bancorp, Raises Price Target to $63 Citigroup Maintains Buy on East West Bancorp, Raises Price Target to $155 Citigroup Maintains Neutral on BOK Financial, Lowers Price Target to $140 Citigroup Maintains Buy on Westinghouse Air Brake, Lowers Price Target to $334 Citigroup Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14 Citigroup Maintains Buy on Pegasystems, Lowers Price Target to $50
